 |
36
72 | f
 |
f
|
25
1d
18
8
18
2
8c
1a
8
49
16
19
1
49
0
1b
1d
18
79
3d
1d
2 29
1d
25
3d
Amna Nabeel Khan, MD, FACE, CCD
6cProfessor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
53
4
3
3
3
2
4
b
1f
53
Perelman Center for Advanced Medicine
20 West Pavilion, 4th Floor
1f 3400 Civic Center Blvd.
8
52 Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center
38 3900 Woodland Avenue.
Philadelphia, PA 19104
26
20 West Pavilion, 4th Floor
1f 3400 Civic Center Blvd.
8
52 Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center
38 3900 Woodland Avenue.
Philadelphia, PA 19104
43
Lab: 215-662-2300
18
f
18
13
Education:
21 a F.Sc. 14 (Biology) c
45 Kinnaird College for Women, Lahore, Pakistan, 1994.
21 9 MBBS c
46 King Edward Medical College, Lahore, Pakistan, 2000.
c
3
27
5
21
21 a F.Sc. 14 (Biology) c
45 Kinnaird College for Women, Lahore, Pakistan, 1994.
21 9 MBBS c
46 King Edward Medical College, Lahore, Pakistan, 2000.
c
1f
Post-Graduate Training
24 55 Internal Medicine, University of Tennessee, Memphis, TN, 2004-2005.
24 5b Internal Medicine, Long Island College Hospital, Brooklyn, NY, 2005-2007.
24 6a Endocrinology, Diabetes and Metabolism, University of Tennessee, Memphis, TN, 2007-2009.
24 a6 Certificate in Healthcare Quality Improvement and Patient Safety, Penn Center for Healthcare Improvement and Patient Safety (Penn CHIPS), 2022-2024.
c
3
25
24 55 Internal Medicine, University of Tennessee, Memphis, TN, 2004-2005.
24 5b Internal Medicine, Long Island College Hospital, Brooklyn, NY, 2005-2007.
24 6a Endocrinology, Diabetes and Metabolism, University of Tennessee, Memphis, TN, 2007-2009.
24 a6 Certificate in Healthcare Quality Improvement and Patient Safety, Penn Center for Healthcare Improvement and Patient Safety (Penn CHIPS), 2022-2024.
c
17
Certifications
28 3c American Board of Internal Medicine, 2007.
28 52 American Board of Endocrinology, Metabolism, and Diabetes, 2009.
28 2c Certified Clinical Densitometrist (CCD) 2 4c International Society for Clinical Densitometry (ISCD), 2014.
28 4b Fellow of American College of Endocrinology (FACE), 2014.
28 51 American Board of Endocrinology, Diabetes and Metabolism, 2019.
28 51 American Board of Endocrinology, Diabetes and Metabolism, 2024.
28 2c Certified Clinical Densitometrist (CCD) 2 4c International Society for Clinical Densitometry (ISCD), 2024.
c
3
8d
Permanent link28 3c American Board of Internal Medicine, 2007.
28 52 American Board of Endocrinology, Metabolism, and Diabetes, 2009.
28 2c Certified Clinical Densitometrist (CCD) 2 4c International Society for Clinical Densitometry (ISCD), 2014.
28 4b Fellow of American College of Endocrinology (FACE), 2014.
28 51 American Board of Endocrinology, Diabetes and Metabolism, 2019.
28 51 American Board of Endocrinology, Diabetes and Metabolism, 2024.
28 2c Certified Clinical Densitometrist (CCD) 2 4c International Society for Clinical Densitometry (ISCD), 2024.
c
2 29
21
1e
1d
24
2b
29
27
23
f4 Amna N. Khan, Robert B. Jones Jr, Nabeel Khan, Yu‑Xiao Yang,Robert A. Adler: Trends in hip fracture rates in US male veterans. Osteoporosis International September 2024.
12d Rashad Madi, Sarem Khan, Chamith S. Rajapakse, Amna N. Khan and Kate Temme: Can Trabecular Bone score Enhance Fracture Risk Assessment in Long Distance Runners with bone Stress Injuries? Clinical Journal of Sports Medicine 2024.
84 Amna N. Khan, MD, Jaliyah Johnson, BSN, Alexia Tsikouras, PharmD, Anna Zuschnitt, PharmD dd : Reduction in the Non-adherence Rate to Denosumab Therapy with Clinical Pharmacy Collaboration: A Quality Improvement Project in an Osteoporosis Clinic. PRESENTED AT THE ANNUAL MEETING OF ASBMR IN VANCOUVER. 21 OCTOBER 2023.
1f0 Lin JK, Hearn CM, Getzen E, Long Q, Lee DC, Keaveny TM, Jayadevappa R, Robinson KW, Wong YN, Maxwell KN, Narayan V, Haas NB, Takvorian SU, Bikle DD, Chiang JM, Khan AN, Rajapakse CS, Morgans AK, Parikh RB.: Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer. Eur Urol Oncol. 2023 Nov 3:S2588-9311(23)00230-4. doi: 10.1016/j.euo.2023.10.016 2023.
b5 Khan AN, Jones RB, Khan N, Yang YX, Adler RA: TRENDS IN HIP FRACTURE RATES IN MALE VETERANS. ANNUAL MEETING, ASBMR, VANCOUVER. 1d OCT 2023.
123 Turin CG, Joeng KS, Kallish S, Raper A, Asher S, Campeau PM, Khan AN, Al Mukaddam M. : Heterozygous variant in WNT1 gene in two brothers with early onset osteoporosis. Bone Reports, 18 Aug 2021 15(101118), August 2021.
104 Amna Khan: Hypophosphatemia Associated with Intravenous Ferric Carboxymaltose Complicated by Multiple Insufficiency Fractures. Presented virtually at the ASBMR Annual Meeting Sept 2020.
f2 Amna Khan: Hypercalcemia Secondary to Calcitriol and PTHrp Cosecretion Only Responsive to Hydroxychloroquine Presented virtually at ENDO 2020 Annual Meeting June 2020.
121 Taher Modaressi, Michael Levine, Julia Tchou, Amna Khan.: Gestational Gigantomastia Complicated By PTHrP-mediated Hypercalcemia J Clin Endocrinol Metab 103(9): 3124-3130, July 2018 Notes: doi:10.1210/jc.2018-01181.
2c
7
1d
1f
Selected Publications
de Marianne Riordan and Amna N. Khan: Efficacy of Romosozumab After Long-Term Denosumab Therapy-A Case Report. Annual Meeting of Endocrine Society 2025.f4 Amna N. Khan, Robert B. Jones Jr, Nabeel Khan, Yu‑Xiao Yang,Robert A. Adler: Trends in hip fracture rates in US male veterans. Osteoporosis International September 2024.
12d Rashad Madi, Sarem Khan, Chamith S. Rajapakse, Amna N. Khan and Kate Temme: Can Trabecular Bone score Enhance Fracture Risk Assessment in Long Distance Runners with bone Stress Injuries? Clinical Journal of Sports Medicine 2024.
84 Amna N. Khan, MD, Jaliyah Johnson, BSN, Alexia Tsikouras, PharmD, Anna Zuschnitt, PharmD dd : Reduction in the Non-adherence Rate to Denosumab Therapy with Clinical Pharmacy Collaboration: A Quality Improvement Project in an Osteoporosis Clinic. PRESENTED AT THE ANNUAL MEETING OF ASBMR IN VANCOUVER. 21 OCTOBER 2023.
1f0 Lin JK, Hearn CM, Getzen E, Long Q, Lee DC, Keaveny TM, Jayadevappa R, Robinson KW, Wong YN, Maxwell KN, Narayan V, Haas NB, Takvorian SU, Bikle DD, Chiang JM, Khan AN, Rajapakse CS, Morgans AK, Parikh RB.: Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer. Eur Urol Oncol. 2023 Nov 3:S2588-9311(23)00230-4. doi: 10.1016/j.euo.2023.10.016 2023.
b5 Khan AN, Jones RB, Khan N, Yang YX, Adler RA: TRENDS IN HIP FRACTURE RATES IN MALE VETERANS. ANNUAL MEETING, ASBMR, VANCOUVER. 1d OCT 2023.
123 Turin CG, Joeng KS, Kallish S, Raper A, Asher S, Campeau PM, Khan AN, Al Mukaddam M. : Heterozygous variant in WNT1 gene in two brothers with early onset osteoporosis. Bone Reports, 18 Aug 2021 15(101118), August 2021.
104 Amna Khan: Hypophosphatemia Associated with Intravenous Ferric Carboxymaltose Complicated by Multiple Insufficiency Fractures. Presented virtually at the ASBMR Annual Meeting Sept 2020.
f2 Amna Khan: Hypercalcemia Secondary to Calcitriol and PTHrp Cosecretion Only Responsive to Hydroxychloroquine Presented virtually at ENDO 2020 Annual Meeting June 2020.
121 Taher Modaressi, Michael Levine, Julia Tchou, Amna Khan.: Gestational Gigantomastia Complicated By PTHrP-mediated Hypercalcemia J Clin Endocrinol Metab 103(9): 3124-3130, July 2018 Notes: doi:10.1210/jc.2018-01181.
2c